Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T08:52:57.416Z Has data issue: false hasContentIssue false

The response to sulpiride in major depression before and after cognitive behavioural therapy: D2 receptor function

Published online by Cambridge University Press:  24 June 2014

Caroline Bell*
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Shamina Bhika
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Richard Porter
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Chris Frampton
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Janet Carter
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Virginia McIntosh
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Jenny Jordan
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
Peter Joyce
Affiliation:
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
*
Dr Caroline Bell, Department of Psychological Medicine, University of Otago, PO Box 4345, Christchurch, New Zealand. Tel: +64 3 372 0400; Fax: +64 3 372 0407; E-mail: caroline.bell@chmeds.ac.nz

Abstract

Background:

Previous studies have suggested that antidepressant treatment of depression may potentiate dopamine transmission through increased sensitivity of postsynaptic D2 receptors.

Method:

D2 receptor function was assessed in 24 patients with major depression before and 16 patients after 16 weeks of treatment with cognitive behavioural therapy (CBT) using a challenge with a selective D2 antagonist, sulpiride. Four hundred milligrams of sulpiride was administered orally on two test days and response was measured by the change in prolactin levels and changes in self-rating scale measures of mood, anxiety and pleasure.

Results:

The prolactin response to sulpiride (as measured by the maximum prolactin level) was significantly increased after CBT (z = −2.792, p = 0.005). Sulpiride resulted in an improvement on mood ratings on both test days, but after CBT, this effect was significantly diminished as measured by the Profile of Mood States score (t = −2.27, p = 0.038).

Conclusions:

After 16 weeks of CBT, we detected an enhanced prolactin response to sulpiride, suggesting an increased sensitivity of D2 receptor functioning.

Information

Type
Research Article
Copyright
Copyright © 2008 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable